Market closed

Sol-Gel Technologies/$SLGL

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Sol-Gel Technologies

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

Ticker

$SLGL
Trading on

Industry

Pharmaceuticals

Headquarters

Ness Ziona, Israel

Employees

34

ISIN

IL0011417206

SLGL Metrics

BasicAdvanced
$21M
-
-$3.80
1.12
-
$21M
1.12
$8.26
$4.11
5.921
5.207
3.043
4.534
-18.51%
-31.35%
1.852
0.74
0.74
-1.538
642.47%
-62.23%
-28.28%
39.58%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $SLGL

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Sol-Gel Technologies stock?

What is the P/E ratio for Sol-Gel Technologies stock?

Does Sol-Gel Technologies stock pay dividends?

When is the next Sol-Gel Technologies dividend payment date?

What is the beta indicator for Sol-Gel Technologies?